Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Why CRISPR Therapeutics Stock Is Sinking Today
Tickers CRSP GILD NVS
Tags NVS Market News GILD
From Motley Fool
For Patient Investors, Tilray Will Deliver Multi-Fold Returns
Tickers NVS TLRY
Tags NASDAQ:TLRY;NYSE:NVS NVS Market News
From InvestorPlace
eFFECTOR Therapeutics Stock Gains On Encouraging Preclinical Zotatifin Data In Breast Cancer
Tickers EFTR NVS
Tags General Movers NVS
From Benzinga
Cannabis Movers & Shakers: TOCC, 1933 Industries, Iter Investments, Greenlane
Tickers BMY GNLN JNJ JNP
Tags Entrepreneurship JNP News
From Benzinga
Death Cross Looms Over Novartis Investors
Tickers NVS
Tags NVS Movers Markets
From Benzinga
Novartis Posts New Data Reinforcing Efficacy, Convenience Of Cosentyx Autoinjector In Psoriasis
Tickers NVS
Tags Biotech Briefs News
From Benzinga
This Potential Indication Could Be a Winner for Novartis
Tickers BGNE NVS
Tags Market News NVS BGNE
From Motley Fool
7 Biotech Stocks Entering the Golden Boom Phase
Tickers ABBV HZNP JNJ LLY
Tags ABBV REGN HZNP
From InvestorPlace
Green Hygienics Holdings To Raise $100M Via Green Bond Offering
Tickers GRYN GSK HEMP NVS
Tags Offerings Hemp GRYN
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Tickers ABSI ADTX AERI AFIB
Tags Market News TRVI TYRA
From Benzinga
Novartis Adds Vision Loss Gene Therapy Program Via Arctos Acquisition
Tickers NVS
Tags Benzinga Market News M&A
From Benzinga
Why Did Deutsche Bank Downgrade This Big Pharma Stock?
Tickers NVS PFE
Tags Analyst Ratings Market News Downgrades
From Benzinga
Novartis' Kisqali Combo Therapy Extends Survival By One Year In Breast Cancer Patients
Tickers NVS
Tags NVS Biotech News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021
Tickers ACHC ADBE AMBP BWA
Tags DNA Downgrades BZI/Ratings
From Benzinga
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
Tickers AGTC APRE BMY BNTX
Tags ZLAB HLTH MRTX
From Benzinga
Novartis' Prostate Cancer Therapy Linked To Improved Quality Of Life
Tickers NVS
Tags prostate cancer Benzinga ESMO21
From Benzinga
Zymeworks' Zanidatamab Aces Mid-Stage Esophageal Cancer Trial
Tickers BGNE NVS ZYME
Tags BGNE News Briefs
From Benzinga
3 Top Chinese Stocks to Watch in September
Tickers AMGN BABA BGNE NVS
Tags BABA TME BGNE
From Motley Fool
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
Tickers CVAC GSK NVS
Tags General COVID/19 Coronavirus GSK
From Benzinga
Why Regenxbio Stock Is Way Up Today
Tickers ABBV NVS RGNX
Tags Market News NVS ABBV
From Motley Fool
ADHD Drug Developer Cingulate Plans NASDAQ Debut
Tickers FRX IPO IPOS JNJ
Tags NVS Briefs News
From Benzinga
3 Red-Hot Healthcare Stocks to Buy in September
Tickers AZN BIIB CRSP DHR
Tags MRNA AZN CRSP
From Motley Fool
3 International Stocks to Buy for Dividend Growth
Tickers DEO NVS UL
Tags Dividend Stocks NYSE:UL,NYSE:DEO,NYSE:NVS UL
From InvestorPlace
Why Did Wedbush Downgrade Xoma?
Tickers NVS XOMA
Tags Analyst Ratings Market News Benzinga
From Benzinga
Novartis Stops Iscalimab Trial In Kidney Transplant Patients
Tickers NVS
Tags Market News Phase 2 Trial kidney disease
From Benzinga
Price Over Earnings Overview: Novartis
Tickers NVS
Tags Markets Intraday Update Market News
From Benzinga
Novartis, NHS England Ink Access Deal For Cholesterol Drug Leqvio
Tickers NVS
Tags cholestrol NVS News
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Tickers AGEN ALKS ALZN BLFS
Tags PDSB NLTX ALKS
From Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
Tickers NVS UCBJF UCBJY
Tags General Briefs News
From Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
Tickers AGEN ALRN AMRX ARGX
Tags DVAX MASI Market News
From Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.